Glatopa Alternatives Compared
Glatopa | Avonex | Diroximel fumarate |
|
---|
Glatopa (glatiramer) | Avonex (interferon beta-1a) | Diroximel fumarate |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Sclerosis. Glatopa may also be used for purposes not listed in this medication guide. |
Prescription only
Avonex is a type of interferon beta-1a that may be used to treat adults with multiple sclerosis (MS). It is administered intramuscularly once weekly into the upper thigh. Headache, flu-like... View more |
Prescription only
Prescribed for Multiple Sclerosis. diroximel fumarate may also be used for purposes not listed in this medication guide. |
||||||||
More about Glatopa (glatiramer) | More about Avonex (interferon beta-1a) | More about Diroximel fumarate | ||||||||
Ratings & Reviews | ||||||||||
Glatopa has an average rating of 4.3 out of 10 from a total of 9 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 43% reported a negative effect. |
Avonex has an average rating of 7.2 out of 10 from a total of 45 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 23% reported a negative effect. |
Diroximel fumarate has an average rating of 9.5 out of 10 from a total of 7 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
Drug Class | ||||||||||
None |
||||||||||
Side Effects | ||||||||||
See also: Glatopa side effects in more detail. |
See also: Avonex side effects in more detail. |
See also: diroximel fumarate side effects in more detail. |
||||||||
Generic Availability | ||||||||||
Lower cost generic approved |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
View all Glatopa prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
|
|
N/A |
||||||||
Brand Names | ||||||||||
Other glatiramer brands include: Copaxone | Other interferon beta-1a brands include: Avonex Pen, Avonex Prefilled Syringe, Rebif, Rebif Rebidose | Vumerity | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
1 hour |
3 hours |
1 hour |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 1 drugs are known to interact with Glatopa:
|
A total of 333 drugs are known to interact with Avonex:
|
A total of 619 drugs are known to interact with diroximel fumarate:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||
Disease Interactions | ||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
First Approval Date | ||||||||||
N/A |
May 17, 1996 |
October 29, 2019 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.